“Building greater resilience in hospitals can be achieved by increasing in-house compounding of SACT(Systemic Anti-Cancer Therapy) within dedicated aseptic compounding units (ACUs)”.
This “helps mitigate the risks associated with relying on outsourced supply chains, which are often fragile and vulnerable to disruptions”.
@mcacrthymt7 “The advantage of on-site compounding is that dose changes or treatment change decisions can be made in real time. Outsourcing to private companies in most cases means ordering SACT 2 weeks in advance. It increases inflexibility in the system. The objective should be to increase efficiency. Maximise onsite SACT compounding.”
Lynch Syndrome Ireland 